FUMIX
Price
$19.18
Change
+$0.15 (+0.79%)
Updated
Sep 4 closing price
Net Assets
4.64B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

FUMIX vs RGEBX

Header iconFUMIX vs RGEBX Comparison
Open Charts FUMIX vs RGEBXBanner chart's image
Fidelity SAI US Momentum Index
Price$19.18
Change+$0.15 (+0.79%)
VolumeN/A
Net Assets4.64B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
FUMIX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FUMIX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FUMIX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. FUMIX (4.64B). FUMIX pays higher dividends than RGEBX: FUMIX (0.42) vs RGEBX (0.00). FUMIX was incepted earlier than RGEBX: FUMIX (9 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than FUMIX (0.13). FUMIX is a more actively managed with annual turnover of: 104.00 vs. RGEBX (25.00). FUMIX has a lower initial minimum investment than RGEBX: FUMIX (0) vs RGEBX (250). FUMIX annual gain was more profitable for investors over the last year : 18.54 vs. RGEBX (17.59). RGEBX return over 5 years is better than : 38.71 vs. FUMIX (22.14).
FUMIXRGEBXFUMIX / RGEBX
Total Expense Ratio0.131.0912%
Annual Report Gross Expense Ratio0.131.0912%
Fund Existence9 years11 years-
Gain YTD14.35415.39893%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets4.64B332B1%
Annual Yield % from dividends0.420.00-
Returns for 1 year18.5417.59105%
Returns for 3 years46.1257.6180%
Returns for 5 years22.1438.7157%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd